日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2.

mAb104 的特性分析,mAb104 是一种靶向 HER2 构象暴露的肿瘤特异性表位的 mAb

Parakh Sagun, Huynh Nhi, Cao Diana Dong, Rigopoulos Angela, Gloria Benjamin, Burvenich Ingrid J G, Murone Carmel, Wichmann Christian W, Guo Nancy Yanan, Senko Clare, Parslow Adam, Allan Laura, Osellame Laura D, Janes Peter W, Scott Fiona E, Liu Zhanqi, Gan Hui K, Scott Andrew M

Characterisation of mAb104 Antibody-Drug Conjugates Targeting a Tumour-Selective HER2 Epitope

靶向肿瘤选择性HER2表位的mAb104抗体-药物偶联物的特性分析

Parakh, Sagun; Huynh, Nhi; Osellame, Laura D; Cao, Diana D; Rigopoulos, Angela; Gloria, Benjamin; Guo, Nancy Yanan; Scott, Fiona E; Liu, Zhanqi; Gan, Hui K; Scott, Andrew M

Correction to: Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with (89)Zr-labelled CI-8993

更正:用 (89)Zr 标记的 CI-8993 靶向免疫检查点调节因子 V 结构域 Ig T 细胞活化抑制因子 (VISTA)

Burvenich, Ingrid Julienne Georgette; Wichmann, Christian Werner; McDonald, Alexander Franklin; Guo, Nancy; Rigopoulos, Angela; Huynh, Nhi; Vail, Mary; Allen, Stacey; O'Keefe, Graeme Joseph; Scott, Fiona Elizabeth; Soikes, Raul; Angelides, Steven; von Roemeling, Reinhard; Scott, Andrew Mark; Julienne, Ingrid; Burvenich, Georgette

Radiolabelling and preclinical characterisation of [(89)Zr]Zr-Df-ATG-101 bispecific to PD-L1/4-1BB

对PD-L1/4-1BB双特异性抗体[(89)Zr]Zr-Df-ATG-101进行放射性标记和临床前表征

Cao, Zhipeng; Wichmann, Christian Werner; Burvenich, Ingrid Julienne Georgette; Osellame, Laura Danielle; Guo, Nancy; Rigopoulos, Angela; O'Keefe, Graeme Joseph; Scott, Fiona Elizabeth; Lorensuhewa, Nirmal; Lynch, Kevin Patrick; Scott, Andrew Mark

Characterization of an Estrogen Receptor α-Selective (18) F-Estradiol PET Tracer

雌激素受体α选择性(18)F-雌二醇PET示踪剂的特性分析

Sluka, Pavel; Ackermann, Uwe; Rigopoulos, Angela; Wardan, Hady; Pezaro, Carmel; Burvenich, Ingrid J G; Scott, Andrew M; Davis, Ian D

Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer

合成并氟-18放射性标记磷脂作为前列腺癌PET成像剂

Kwan, Kim H; Burvenich, Ingrid J G; Centenera, Margaret M; Goh, Yit Wooi; Rigopoulos, Angela; Dehairs, Jonas; Swinnen, Johannes V; Raj, Ganesh V; Hoy, Andrew J; Butler, Lisa M; Scott, Andrew M; White, Jonathan M; Ackermann, Uwe

In Vitro and In Vivo Evaluation of (89)Zr-DS-8273a as a Theranostic for Anti-Death Receptor 5 Therapy

体外和体内评价 (89)Zr-DS-8273a 作为抗死亡受体 5 疗法的诊疗一体化药物

Burvenich, Ingrid J G; Lee, Fook-Thean; Guo, Nancy; Gan, Hui K; Rigopoulos, Angela; Parslow, Adam C; O'Keefe, Graeme J; Gong, Sylvia J; Tochon-Danguy, Henri; Rudd, Stacey E; Donnelly, Paul S; Kotsuma, Masakatsu; Ohtsuka, Toshiaki; Senaldi, Giorgio; Scott, Andrew M

L-Tyrosine Confers Residualizing Properties to a d-Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies

L-酪氨酸赋予富含D-氨基酸的残留肽残留特性,用于放射性碘化内化抗体

Lee, Fook T; Burvenich, Ingrid J G; Guo, Nancy; Kocovski, Pece; Tochon-Danguy, Henri; Ackermann, Uwe; O'Keefe, Graeme J; Gong, Sylvia; Rigopoulos, Angela; Liu, Zhanqi; Gan, Hui K; Scott, Andrew M

Correction: Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways

更正:西妥昔单抗和贝伐珠单抗治疗结直肠肿瘤的分子谱分析揭示了代谢和缺氧反应通路的紊乱

Greening, David W; Lee, Sze Ting; Ji, Hong; Simpson, Richard J; Rigopoulos, Angela; Murone, Carmel; Fang, Catherine; Gong, Sylvia; O'Keefe, Graeme; Scott, Andrew M

Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways.

对西妥昔单抗和贝伐珠单抗治疗结直肠肿瘤的分子谱分析揭示了代谢和缺氧反应通路的扰动

Greening David W, Lee Sze Ting, Ji Hong, Simpson Richard J, Rigopoulos Angela, Murone Carmel, Fang Catherine, Gong Sylvia, O'Keefe Graeme, Scott Andrew M